ImmunOs Therapeutics has closed an oversubscribed Series B financing round totaling USD 74 million. The round was led by new investors Samsara BioCapital, Lightspeed Venture Partners, and Gimv, and joined by new investors Mission BioCapital, GL
Tags :Slider
After its successful product launch in September 2021, Swiss fintech start-up Numerics has just closed a CHF 2.1 million pre-seed financing round led by Wingman Ventures and Seed X Liechtenstein. Numarics is Zurich based start-up that offers
GP Investments, majority shareholder of Spice Private Equity, has pre-announced its public tender offer for all publicly held shares in SIX listed Spice Private Equity. GP Investments intends to increase its equity share in Spice
Investment Latour has, through its wholly-owned subsidiary Swegon Group, acquired Barcol-Air, a leading supplier of radiant ceiling systems. The acquisition of Barcol-Air means that Swegon continue to build on its already strong position within radiant
Perfect Holding announced the completion of the reverse takeover transaction (RTO) with Kinarus, a clinical-stage biopharmaceutical company engaged in the discovery and development of novel therapeutics for the treatment of viral, respiratory, and ophthalmic disease.
Kering completed the sale of Sowind Group, which owns the Swiss watch manufacturers Girard-Perregaux and Ulysse Nardin, to Sowind’s management. The luxury Group has supported the two Houses in their development, strengthened their positioning
Credit Suisse has successfully completed its issuance of €1 billion aggregate principal amount of 2.125% senior notes due 2024 and €750 million aggregate principal amount of floating rate senior notes due 2024. The bonds were issued under Credit Suisse’s
Thun-based TOFWERK has concluded a strategic partnership with Bruker Corporation for applied and industrial analytical solutions, in conjunction with a Bruker minority investment in TOFWERK. The NASDAQ-listed US tech company Bruker Corporation is a
HomeToGo announced the acquisition of Frankfurt-based internet company e-domizil from e-vacation Group Holding for €40 million. The purchase price includes a payment of around €2 million in class A shares owned by HomeToGo, which is subject to
VISCHER has advised ADVANZ PHARMA, a specialty pharmaceutical company headquartered in London, on all Swiss legal aspects of its USD 450m acquisition of the ex-US business of Intercept Pharmaceuticals, spanning from due diligence to transactional
